363 related articles for article (PubMed ID: 26942409)
1. Bovine Gamma Delta T Cells Contribute to Exacerbated IL-17 Production in Response to Co-Infection with Bovine RSV and Mannheimia haemolytica.
McGill JL; Rusk RA; Guerra-Maupome M; Briggs RE; Sacco RE
PLoS One; 2016; 11(3):e0151083. PubMed ID: 26942409
[TBL] [Abstract][Full Text] [Related]
2. γδ T cells and the immune response to respiratory syncytial virus infection.
McGill JL; Sacco RE
Vet Immunol Immunopathol; 2016 Nov; 181():24-29. PubMed ID: 26923879
[TBL] [Abstract][Full Text] [Related]
3. Immune responses to bovine respiratory syncytial virus (BRSV) following use of an inactivated BRSV-PI3-Mannheimia haemolytica vaccine and a modified live BRSV-BVDV vaccine.
Kerkhofs P; Tignon M; Petry H; Mawhinney I; Sustronck B
Vet J; 2004 Mar; 167(2):208-10. PubMed ID: 14975397
[No Abstract] [Full Text] [Related]
4. Vaccination with recombinant modified vaccinia virus Ankara expressing bovine respiratory syncytial virus (bRSV) proteins protects calves against RSV challenge.
Antonis AF; van der Most RG; Suezer Y; Stockhofe-Zurwieden N; Daus F; Sutter G; Schrijver RS
Vaccine; 2007 Jun; 25(25):4818-27. PubMed ID: 17499893
[TBL] [Abstract][Full Text] [Related]
5. Vaccine safety and efficacy evaluation of a recombinant bovine respiratory syncytial virus (BRSV) with deletion of the SH gene and subunit vaccines based on recombinant human RSV proteins: N-nanorings, P and M2-1, in calves with maternal antibodies.
Blodörn K; Hägglund S; Fix J; Dubuquoy C; Makabi-Panzu B; Thom M; Karlsson P; Roque JL; Karlstam E; Pringle J; Eléouët JF; Riffault S; Taylor G; Valarcher JF
PLoS One; 2014; 9(6):e100392. PubMed ID: 24945377
[TBL] [Abstract][Full Text] [Related]
6. Differential chemokine and cytokine production by neonatal bovine γδ T-cell subsets in response to viral toll-like receptor agonists and in vivo respiratory syncytial virus infection.
McGill JL; Nonnecke BJ; Lippolis JD; Reinhardt TA; Sacco RE
Immunology; 2013 Jun; 139(2):227-44. PubMed ID: 23368631
[TBL] [Abstract][Full Text] [Related]
7. Bovine model of respiratory syncytial virus infection.
Taylor G
Curr Top Microbiol Immunol; 2013; 372():327-45. PubMed ID: 24362697
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of mucosal polyanhydride nanovaccine against respiratory syncytial virus infection in the neonatal calf.
McGill JL; Kelly SM; Kumar P; Speckhart S; Haughney SL; Henningson J; Narasimhan B; Sacco RE
Sci Rep; 2018 Feb; 8(1):3021. PubMed ID: 29445124
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic digoxin treatment reduces IL-17 production in vivo in the neonatal calf and moderates RSV-associated disease.
McGill JL; Guerra-Maupome M; Schneider S
PLoS One; 2019; 14(3):e0214407. PubMed ID: 30908540
[TBL] [Abstract][Full Text] [Related]
10. Association of bovine respiratory disease or vaccination with serologic response in dairy heifer calves up to three months of age.
Windeyer MC; Leslie KE; Godden SM; Hodgins DC; Lissemore KD; LeBlanc SJ
Am J Vet Res; 2015 Mar; 76(3):239-45. PubMed ID: 25710760
[TBL] [Abstract][Full Text] [Related]
11. Kinetics of antiviral CD8 T cell responses during primary and post-vaccination secondary bovine respiratory syncytial virus infection.
Antonis AF; Claassen EA; Hensen EJ; de Groot RJ; de Groot-Mijnes JD; Schrijver RS; van der Most RG
Vaccine; 2006 Mar; 24(10):1551-61. PubMed ID: 16310293
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of a virus-vectored vaccine against human and bovine respiratory syncytial virus infections.
Taylor G; Thom M; Capone S; Pierantoni A; Guzman E; Herbert R; Scarselli E; Napolitano F; Giuliani A; Folgori A; Colloca S; Cortese R; Nicosia A; Vitelli A
Sci Transl Med; 2015 Aug; 7(300):300ra127. PubMed ID: 26268314
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxic T lymphocyte activity and cytokine expression in calves vaccinated with formalin-inactivated bovine respiratory syncytial virus prior to challenge.
Woolums AR; Gunther RA; McArthur-Vaughan K; Anderson ML; Omlor A; Boyle GA; Friebertshauser KE; McInturff PS; Gershwin LJ
Comp Immunol Microbiol Infect Dis; 2004 Jan; 27(1):57-74. PubMed ID: 14656542
[TBL] [Abstract][Full Text] [Related]
14. Effects of exposure to calves persistently infected with bovine viral diarrhea virus type 1b and subsequent infection with Mannheima haemolytica on clinical signs and immune variables: model for bovine respiratory disease via viral and bacterial interaction.
Burciaga-Robles LO; Step DL; Krehbiel CR; Holland BP; Richards CJ; Montelongo MA; Confer AW; Fulton RW
J Anim Sci; 2010 Jun; 88(6):2166-78. PubMed ID: 20154164
[TBL] [Abstract][Full Text] [Related]
15. Recombinant vaccinia viruses expressing the F, G or N, but not the M2, protein of bovine respiratory syncytial virus (BRSV) induce resistance to BRSV challenge in the calf and protect against the development of pneumonic lesions.
Taylor G; Thomas LH; Furze JM; Cook RS; Wyld SG; Lerch R; Hardy R; Wertz GW
J Gen Virol; 1997 Dec; 78 ( Pt 12)():3195-206. PubMed ID: 9400970
[TBL] [Abstract][Full Text] [Related]
16. Vitamin A deficiency impairs the immune response to intranasal vaccination and RSV infection in neonatal calves.
McGill JL; Kelly SM; Guerra-Maupome M; Winkley E; Henningson J; Narasimhan B; Sacco RE
Sci Rep; 2019 Oct; 9(1):15157. PubMed ID: 31641172
[TBL] [Abstract][Full Text] [Related]
17. Bovine respiratory syncytial virus-specific IgE is associated with interleukin-2 and -4, and interferon-gamma expression in pulmonary lymph of experimentally infected calves.
Gershwin LJ; Gunther RA; Anderson ML; Woolums AR; McArthur-Vaughan K; Randel KE; Boyle GA; Friebertshauser KE; McInturff PS
Am J Vet Res; 2000 Mar; 61(3):291-8. PubMed ID: 10714521
[TBL] [Abstract][Full Text] [Related]
18. Chimeric bovine respiratory syncytial virus with glycoprotein gene substitutions from human respiratory syncytial virus (HRSV): effects on host range and evaluation as a live-attenuated HRSV vaccine.
Buchholz UJ; Granzow H; Schuldt K; Whitehead SS; Murphy BR; Collins PL
J Virol; 2000 Feb; 74(3):1187-99. PubMed ID: 10627529
[TBL] [Abstract][Full Text] [Related]
19. A bovine respiratory syncytial virus model with high clinical expression in calves with specific passive immunity.
Blodörn K; Hägglund S; Gavier-Widen D; Eléouët JF; Riffault S; Pringle J; Taylor G; Valarcher JF
BMC Vet Res; 2015 Mar; 11():76. PubMed ID: 25890239
[TBL] [Abstract][Full Text] [Related]
20. Immunology of bovine respiratory syncytial virus infection of cattle.
Gershwin LJ
Comp Immunol Microbiol Infect Dis; 2012 May; 35(3):253-7. PubMed ID: 22410266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
